# Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD

> **NCT04891588** · NA · UNKNOWN · sponsor: **Klinički Bolnički Centar Zagreb** · enrollment: 50 (estimated)

## Conditions studied

- Primary Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Switching the preserved prostaglandin analog-timolol FC to Fixalpost (preservative free prostaglandin analog-timolol FC)

## Key facts

- **NCT ID:** NCT04891588
- **Lead sponsor:** Klinički Bolnički Centar Zagreb
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-08
- **Primary completion:** 2021-09-08
- **Final completion:** 2021-12-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04891588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04891588, "Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04891588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*